Peptide aptamers with biological and therapeutic applications

Current Medicinal Chemistry

Volumn 18, Issue 27, 2011, Pages 4215-4222

  Li, J ^a   Tan, S ^a   Chen, X ^a   Zhang, C Y ^a   Zhang, Y ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Anticancer; Antivirus; Peptide aptamers; Protein function modulation; Target protein; Therapeutic application

Indexed keywords

6B4 PEPTIDE APTAMER; AGR2 PEPTIDE APTAMER; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; APT48 PEPTIDE APTAMER; CYCLIN DEPENDENT KINASE; HEPATITIS B CORE ANTIGEN; KDI1 PEPTIDE APTAMER; PA207 PEPTIDE APTAMER; PA34 PEPTIDE APTAMER; PA72 PEPTIDE APTAMER; PBMT101 PEPTIDE APTAMER; PEP2 PEPTIDE APTAMER; PEP4 PEPTIDE APTAMER; PEP8 PEPTIDE APTAMER; PEPTIDE APTAMER; PROTEIN P53; SWIGGLE PEPTIDE APTAMER; TRIP PEPTIDE APTAMER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BINDING AFFINITY; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; DRUG ACTIVITY; DRUG BINDING SITE; DRUG TARGETING; HUMAN; IN VITRO STUDY; NONHUMAN; PROTEIN ANALYSIS; REVIEW; VACCINIA VIRUS; VIRUS REPLICATION; WART VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; APTAMERS, PEPTIDE; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; SELEX APTAMER TECHNIQUE;

EID: 80052236414     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797189583     Document Type: Review

References (61)

1. Hoppe-Seyler, F.; Crnkovic-Mertens, I.; Denk, C.; Fitscher, B.A.; Klevenz, B.; Tomai, E.; Butz, K. Peptide aptamers: new tools to study protein interactions. J. Steroid. Biochem., 2001, 78(2), 105-111. (Pubitemid 32879325)
2. Hoppe-Seyler, F.; Butz, K. Peptide aptamers: powerful new tools for molecular medicine. J. Mol. Med., 2000, 78(8), 426-430.
3. Khati, M. The future of aptamers in medicine. J. Clin. Pathol., 2010, 63(6), 480-487.
4. Borghouts, C.; Kunz, C.; Groner, B. Peptide aptamer libraries. Comb. Chem. High. Throughput Screen, 2008, 11(2), 135-145 (Pubitemid 351347218)
5. Colas, P.; Cohen, B.; Jessen, T.; Grishina, I.; McCoy, J.; Brent, R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature, 1996, 380(6574), 548-550. (Pubitemid 26110646)
6. Crawford, M.; Woodman, R.; Ko Ferrigno, P. Peptide aptamers: Tools for biology and drug discovery. Brief. Funct. Genomics. Proteomi., 2003, 2(1), 72-79.
7. Lopez-Ochoa, L.; Nash, T.E.; Ramirez-Prado, J.; Hanley-Bowdoin, L., Isolation of Peptide Aptamers to Target Protein Function, Methods Mol. Biol., 2009, 535, 333-360.
8. Norman, T. C.; Smith, D. L.; Sorger, P.K.; Drees, B. L.; O'Rourke, S. M.; Hughes, T. R.; Roberts, C. J.; Friend, S. H.; Fields, S.; Murray, A. W., Genetic selection of peptide inhibitors of biological pathways, Science, 1999, 285, 591-595.
9. Cohen, B.A.; Colas, P.; Brent, R. An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc. Natl. Acad. Sci. USA., 1998, 95(24), 14272-14277. (Pubitemid 28549357)
10. Cheng X.; Boyer J.L.; Juliano R. L., Selection of peptides that functionally replace a zinc finger in the Sp1 transcription factor by using a yeast combinatorial library, Proc. Natl. Acad. Sci. USA., 1997, 94(25), 14120-14125. (Pubitemid 28009720)
11. Caponigro, G.; Abedi, M.R.; Hurlburt, A.P.; Maxfield, A.; Judd, W.; Kamb, A. Transdominant genetic analysis of a growth control pathway. Proc. Natl. Acad. Sci. USA., 1998, 95(13), 7508-7513. (Pubitemid 28293283)
12. Klevenz, B.; Butz, K. Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding. Cell. Mol. Life. Sci., 2002, 59(11), 1993-1998. (Pubitemid 36015871)
13. Woodman, R.; Yeh, J. T. H.; Laurenson, S.; Po Ferrigno, K. Design and Validation of a Neutral Protein Scaffold for the Presentation of Peptide Aptamers, J. Mol. Biol., 2005, 352(5), 1118-1133. (Pubitemid 41316720)
14. Bickle, M.B.T.; Dusserre, E.; Moncorgé, O.; Bottin, H.; Colas, P. Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures. Nat. Protoc., 2006, 1(3), 1066-1091.
15. Bardou, C.; Borie, C.; Bickle, M.; Rudkin, B. B.; Colas, P. Peptide aptmaers for small molecule drug discovery, Methods Mol. Biol., 2009, 535, 373-388.
16. Davis, J. J.; Tkac, J.; Laurenson, S.; Ko Ferrigno, P. Peptide Aptamers in Label-Free Protein Detection:l Characterization of the Immobilized Scaffold. Anal. Chem., 2007, 79(3), 1089-1096.
17. Johnson, S.; Evans, D.; Laurenson, S.; Paul, D.; Davies, A. G.; Ko Ferrigno, P.; Wälti, C. Surface-Immobilized Peptide Aptamers as Probe. Molecules for Protein Detection. Anal. Chem., 2008, 80(4), 978-983. (Pubitemid 351272327)
18. Davis, J. J.; Tkac, J.; Humphreys, R.; Buxton, A. T.; Lee, T. A.; Ko- Ferrigno, P. Peptide Aptamers in Label-Free Protein Detection: 2. Chemical Optimization and Detection of Distinct. Anal. Chem., 2009, 81(9), 3314-3320.
19. Evans, D.; Johnson, S.; Laurenson, S.; Davies, A.G.; Ko-Ferrigno P.; Wälti, C. Electrical protein detection in cell lysates using high-density peptideaptamer microarrays. J. Biol., 2008, 7(1), 3.
20. Estrela, P.; Paul, D.; Song, Q.; Stadler, L.; Wang, L.; Huq, E.; Davis, J.; Ko Ferrigno, P.; Migliorato, P. Label-free sub-picomolar protein detection with field-effect transistors. Anal. Chem., 2010, 82(9), 3531-3536.
21. Laurenson, S.; Pett, M. R.; Hoppe-Seyler, K.; Denk, C.; Hoppe-Seyler, F.; Coleman, N.; Ko Ferrigno, P. Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts. Anal. Biochem., 2011, 410(2), 161-170.
22. Guezennec, X. L.; Vermeulen M.; Stunnenberg, H. G. Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners. Nucleic. Acids. Res., 2006, 34(14), 3929-3937. (Pubitemid 44391008)
23. Murray, E.; McKenna, E.O.; Burch, L.R.; Dillon, J.; Langridge-Smith, P.; Kolch, W.; Pitt, A.; Hupp, T.R. Microarray-Formatted Clinical Biomarker Assay Development Using Peptide Aptamers to Anterior Gradient-2. Biochem., 2007, 46(48),13742-13751. (Pubitemid 350223902)
24. Min, K.; Song, K. M.; Cho, M.; Chun, Y. S.; Shim, Y.B.; Ku, J. K.; Ban, C. Simultaneous electrochemical detection of both PSMA(+)and PSMA(-) prostate cancer cells using an RNA/peptide dual-aptamer probe. Chem. Commun., 2010, 46(30), 5566-5568.
25. Hoppe-Seyler, F.; Crnkovic-Mertens, I.; Tomai, E.; Butz, K. Peptide Aptamers: Specific Inhibitors of Protein Function. Curr. Mol. Med., 2004, 4(5), 529-538. (Pubitemid 38961196)
26. Kitamura, K.; Yoshida, C.; Kinoshita, Y.; Kadowaki, T.; Takahashi, Y.; Tayama, T.; Kawakubo, T.; Naimuddin, M.; Salimullah, M.; Nemoto, N.; Hanada, K.; Husimi, Y.; Yamamoto, K.; Nishigaki, K. Development of Systemic in vitro Evolution and Its Application to Generation of Peptide-Aptamer-Based Inhibitors of Cathepsin E. J. Mol. Biol., 2009, 387(5), 1186-1198.
27. Blum, J.H.; Dove, S.L.; Hochschild, A.; Mekalanos, J.J. Isolation of peptide aptamers that inhibit intracellular processes. Proc. Natl. Acad. Sci. USA., 2000, 97(5), 2241-2246. (Pubitemid 30134053)
28. Colas, P. Combinatorial protein reagents to manipulate protein function. Curr. Opin. Chem. Biol., 2000, 4(1), 54-59. (Pubitemid 30098673)
29. Chattopadhyay, A.; Tatel, S.A.; Beswick, R.W.; Wagner S.D.; Ko Ferrigno, P. A peptide aptamer to antagonize BCL-6 function. Oncogene, 2006, 25(15), 2223-2233.
30. Cui, Q.; Lim, S.K.; Zhao B.; Hoffmann, F.M. Selective inhibition of TGF-β responsive genes by Smad-interacting peptide aptamers from FoxHl, Lefl and CBP. Oncogene, 2005, 24(24), 3864-3874. (Pubitemid 40896398)
31. Wickramasinghe, R.D.; Ko Ferrigno, P.; Roghi C. Peptide aptamers as new tools to modulate clathrin-mediated internalisation-inhibition of MT1-MMP internalisation. BMC. Cell. Biol., 2010, 11(58), 1471-2121.
32. Xu, C.W.; Luo, Z.J. Inactivation of Ras function by allele-specific peptide aptamers. Oncogene, 2002, 21(37), 5753-5757. (Pubitemid 35333008)
33. Stevens, C.; Hupp, T.R. Novel insights into DAPK autophagic signaling using peptide aptamer combinatorial protein-interaction screens. Autophagy, 2008, 4(4), 531-533. (Pubitemid 351705155)
34. Stevens, C.; Lin, Y.; Harrison, B.; Burch, L.; Ridgway, R.A.; Sansom, O.; Hupp, T. Peptide Combinatorial Libraries Identify TSC2 as a Deathassociated Protein Kinase (DAPK) Death Domain-binding Protein and Reveal a Stimulatory Role for DAPK in mTORC1 Signaling, J. Biol. Chem., 2009, 284(1), 334-344.
35. Geyer, C.R.; Colman-Lerner, A.; Brent R. "Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections. Proc. Natl. Acad. Sci. USA., 1999, 96(15), 8567-8572. (Pubitemid 29354832)
36. Appert, A.; Nam, C.H.; Lobato, N.; Priego, E.; Miguel, R.N.; Blundell, T.; Drynan, L.; Sewell, H.; Tanaka, T.; Rabbitts. T. Targeting LMO2 with a Peptide Aptamer Establishes a Necessary Function in Overt T-Cell Neoplasia. Cancer. Res., 2009, 69(11), 4784-4790.
37. Martel, V.; Filhol, O.; Colas, P.; Cochet, C. p53-dependent inhibition of mammalian cell survival bya genetically selected peptide aptamer that targets the regulatorysubunit of protein kinase CK2. Oncogene, 2006, 25(56), 7343-7353. (Pubitemid 44853425)
38. Lim, S.K.; Hoffmann, F.M. Smad4 cooperates with lymphoid enhancerbinding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-signaling. Proc. Natl. Acad. Sci. USA., 2006, 103(49), 18580-18585. (Pubitemid 44913453)
39. Kolonin, M.G.; Finley, R.L.Jr. Targeting cyclin-dependent kinases in Drosophila with peptide ptamers. Proc. Natl. Acad. Sci. USA., 1998, 95(24): 14266-14271. (Pubitemid 28549356)
40. Butz, K.; Denk, C.; Fitscher, B.; Crnkovic-Mertens, I.; Ullmann, A.; Schröder, C.H.; Hoppe-Seyler, F. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene, 2001, 20(45), 6579-6586. (Pubitemid 32980284)
41. Tomai, E.; Butz, K.; Lohrey, C.; von Weizsäcker, F.; Zentgraf H.; Hoppe-Seyler F. Peptide Aptamer-mediated Inhibition of Target Proteins by Sequestration into Aggresomes. J. Bio. Chem., 2006, 281(30), 21345-21352. (Pubitemid 44115473)
42. Litovchick, A.; Szostak, J.W. Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA display. Proc. Natl. Acad. Sci. USA., 2008, 105(40), 15293-15298.
43. Saccucci, L.; Crance, J.M.; Colas, P.; Bickle, M.; Garin, D.; Iseni, F. Inhibition of vaccinia virus replication by peptide aptamers. Antivir. Res., 2009, 82(3), 134-140.
44. Trahtenherts, A.; Gal-Tanamy, M.; Zemel, R.; Bachmatov, L.; Loewenstein, S.; Tur-Kaspa, R.; Benhar, I. Inhibition of hepatitis C virus RNA replicons by peptide aptamers. Antivir. Res., 2008, 77(3), 195-205.
45. Kaiser, N.; Lischka, P.; Wagenknecht, N.; Stamminger, T. Inhibition of Human Cytomegalovirus Replication via Peptide Aptamers Directed against the Nonconventional Nuclear Localization Signal of the Essential Viral Replication Factor pUL84. J. Virol., 2009, 83(22), 11902-11913.
46. Borghouts, C.; Kunz, C.; Gronert, B. Peptide aptamers: recent developments for cancer therapy. Expert. Opin. Biol. Ther., 2005, 5(6):783-797. (Pubitemid 40873887)
47. Fourtouna, A.; Murray, E.; Nicholson, J.; Maslon, M.M.; Pang, L.Y.; Dryden, D.T.F.; Hupp, T.R. The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function. Curr. Chem. Biol., 2009, 3(2), 124-137.
48. Guida, E.; Bisso, A.; Fenollar-Ferrer, C.; Napoli, M.; Anselmi, C.; Girardini, J.E.; Carloni, P.; Del Sal, G. Peptide Aptamers Targeting Mutant p53 Induce Apoptosis in Tumor Cells. Cancer. Res., 2008, 68(16), 6550-6558.
49. Buerger, C.; Nagel-Wolfrum, K.; Kunz, C.; Wittig, I.; Butz, K.; Hoppe- Seyler, F.; Groner, B. Sequence-specific Peptide Aptamers, Interacting with the intracellular Domain of the Epidermal Growth Factor Receptor, Interfere with Stat3 Activation and Inhibit the Growth of Tumor Cells. J. Biol. Chem., 2003, 278(39), 37610-37621. (Pubitemid 37175284)
50. Hoppe-Seyler, F.; Dymalla, S.; Moosmeier, M.A.; Hoppe-Seyler, K., Peptide aptamers targeting the viral E6 oncoprotein induce apoptosis in HPVpositive cancer cells, Peptides as Drugs: Discovery and Development, 2009, 57-72.
51. Butz, K.; Denk, C.; Ullmann, A.; Scheffner, M.; Hoppe-Seyler, F. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl. Acad. Sci. USA., 2000, 97(12), 6693-6697. (Pubitemid 30412776)
52. Mern, D.S.; Hoppe-Seyler, K.; Hoppe-Seyler, F.; Hasskarl, J.; Burwinkel, B. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast. Cancer. Res. Treat., 2010, 124(3), 623-633.
53. Mern, D.S.; Hasskarl, J.; Burwinkel, B. Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells. Brit. J. Cancer., 2010, 103(8), 1237-1244.
54. Bouquier, N.; Fromont, S,; Zeeh, J.C.; Auziol, C,; Larrousse, P.; Robert, B.; Zeghouf, M.; Cherfils, J.; Debant A.; Schmidt, S. Aptamer-Derived Peptides as Potent Inhibitors of the Oncogenic RhoGEF Tgat. Chem. Biol., 2009, 16(4), 391-400.
55. Gibert, B.; Hadchity, E.; Czekalla, A.; Aloy, M. T.; Colas, P.; Rodriguez- Lafrasse, C.; Arrigo, A.-P.; Diaz-Latoud, C. Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers. Oncogene, 2011, 1-10.
56. Rérole, A.L.; Gobbo, J.; De Thonel, A.; Schmitt, E.; Pais de Barros, J.P.; Hammann, A.; Lanneau, D.; Fourmaux, E.; Deminov, O.; Micheau, O.; Lagrost, L.; Colas, P.; Kroemer, G.; Garrido, C. Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy. Cancer. Res., 2011, 71(2), 484-495.
57. Kunz, C.; Borghouts, C.; Buerger, C.; Groner, B. Peptide Aptamers with Binding Specificity for the Intracellular Domain of the ErbB2 Receptor Interfere with AKT Signaling and Sensitize Breast Cancer Cells to Taxol. Mol. Cancer. Res., 2006, 4(12), 983-998.
58. Baines, I.C.; Colas, P. Peptide aptamers as guides for small molecule drug discovery. Drug. Discov. Today., 2006, 11(7/8), 334-341.
59. Aita, T.; Nishigaki, K.; Husimi, Y. Toward the fast blind docking of a peptide to a target protein by using a four-body statistical pseudo-potential. Comput. Biol. Chem., 2010, 34(1), 53-62.
60. Yoshikawa, T.; Sugita, T.; Mukai, Y.; Yamanada, N.; Nagano, K,; Nabeshi, H.; Yoshioka, Y.; Nakagawa, S.; Abe, Y.; Kamada, H.:Tsunoda, S.; Tsutsumi, Y. Organelle-Targeted Delivery of Biological Macromolecules Using the Protein Transduction Domain: Potential Applications for Peptide Aptamer Delivery into the Nucleus. J. Mol. Biol., 2008, 380(5), 777-782.
61. Shiba, K. Functionalization of carbon nanomaterials by evolutionary molecular engineering: Potential application in drug delivery systems. J. Drug. Target., 2006, 14(7), 512-518. (Pubitemid 44592903)